胃肠转流手术与2型糖尿病

耿翔, 周晓云

耿翔, 周晓云. 胃肠转流手术与2型糖尿病[J]. 实用临床医药杂志, 2013, (7): 160-162. DOI: 10.7619/jcmp.201307060
引用本文: 耿翔, 周晓云. 胃肠转流手术与2型糖尿病[J]. 实用临床医药杂志, 2013, (7): 160-162. DOI: 10.7619/jcmp.201307060

胃肠转流手术与2型糖尿病

详细信息
  • 中图分类号: R587.1

  • 摘要: 糖尿病是严重危害人类健康的慢性疾病之一,目前全球有糖尿病患者约1.7亿,到2030年预计将达到3.66亿,其中85%~90%为2型糖尿病(T2DM)[1].2型糖尿病是由于胰岛素抵抗和β细胞分泌缺陷导致高血糖的一种复杂多基因疾病,目前降低2型糖尿病并发症主要通过严格控制高血糖,包括饮食、运动、口服降糖药及使用胰岛素,但很少能使患者的血糖恢复正常水平.近年来,国外研究者通过对接受肥胖症胃转流手术的患者的长期随访后发现,胃肠转流术可以长期稳定地缓解2型糖尿病,并能减少糖尿病并发症,为2型糖尿病的外科治疗开辟了新途径.现就胃转流术治疗2型糖尿病综述如下.
  • Wild S, Roglie G, Green A. Global prevalence of diabetes [J]. Diabetes Care, 2004(5):1047.
    BULT MJ, AN DALEN T, MULLER AF. Surgical treatment of obesity [J]. European Journal of Endocrinology, 2008(2):135.
    Adams T D, Gress R E, Smith S C. Long-term mortality after gastric bypass surgery [J]. New England Journal of Medicine, 2007.753.
    Wittgrove, Wesley Clark. Laparoscopic gastric bypass.Roux-en-Y:Preliminary report of five cases [J]. Obesity Surgery, 1994(4):353.
    Cummings D E, Overdun J. Gastric bypass for obesity:mecganisms of weisht loss and diabetes resolution [J]. JClin Endocri Metab, 2004(6):2608.
    Scopinaro N. Biliopancreatic diversion:mechanisms of action and long-term results [J]. Obesity Surgery, 2006.683.
    Mottin C C, Vontobel Padoin A, Schroer C E. Behavior of type 2 diabetes mellitus in morbid obese patients submitted to gastric bypass [J]. Obesity Surgery, 2008(2):179.
    Lakdawala M, Bhasker A. Asian Consensus Meeting on Metabolic Surgery (ACMOMS).Report:Asian Consensus Meeting on Metaboilc Surgery.Recommendations for the use of Bariatric and Gastrointestinal Metaboilc Surgery for Treatment of Obesity and Type Ⅱ Diabetes Mellitus in the Asian Population.9th and 10th, 2008, Trivandrum India [J]. Obesity Surgery, 2010.929.
    Lee W J, Wang W. Bariatric surgery:Asia-pacific perspective [J]. Obesity Surgery, 2005(6):751.
    American Diabetes Association. Standards of medical care in diabetes-2011 [J]. Diabetes Care, 2011, (1):S11.doi: 10.3969/j.issn.1672-7851.2011.01.003.
    Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obcsc aninml model of type 2 diabetes; a new perspective for an old dlsease [J]. Annals of Surgery, 2004(1):1.
    Scopinaro N, Adami G F, Papadia F S. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 [J]. Annals of Surgery, 2011.699.
    Schauer P R, Burguera B, IkrarnuddinS. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus [J]. Annals of Surgery, 2003(4):467.
    Mason EE. Ileal[correction of ilial]transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery [J]. Obesity Surgery, 1999(3):223.
    Patfiti A, Facchiano E, Annetti C. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model [J]. Obesity Surgery, 2005(9):1258.
    MEIRELLES K, AHMED T, DEREK M. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat [J]. Annals of Surgery, 2009(2):277.
    Winzell MS, Nogueiras R, Dieguez C. Dual action of adiponectin on insulin secretion in insulin-resistant mice [J]. Biochemical and Biophysical Research Communications, 2004(1):154.
    MIYAWAKI K, YAMADA Y, BAN N. nhibition of gastric inhibitory polypeptide signaling prevents obesity [J]. Nature Medicine, 2002(7):738.
    FLATT P R. Effective surgical treatment of obesity may be mediated by ablation of the lipegenic gut hormone gastric inhibitory polypeptide(GIP):evidence and clinical opportunity for development of new obesity-diabetes drugs [J]. Diab Vasc Dis Res, 2007(2):151.
    Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus [J]. Annals of Surgery, 2002(5):554.
    Rubino F, Gagner M, Gentileschi P. The early effect of the Roux-en-Ygastric bypass on hormones involved in body weight and glucose metabolism [J]. Annals of Surgery, 2004(2):236.
    Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus [J]. Annals of Surgery, 2002(5):554.
    Moo T A, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes [J]. Curr Opin Endocrinol Diabetes Obes, 2008(2):153.
    Bahhio L L, Drucker D J. Biology of incretins:GLP-1 and GIP [J]. Gastroenterology, 2007(6):2131.
    Drucker D J. Glucagon-like peptide-1 and the islet beta-cell:augmentation0f cell proliferation and inhibition of apoptosis [J]. Endocrinology, 2003, (12):5145.
    Service G J, Thompaen G B, Service F J. Hyperinsuline-mic hypoglycemis with neaidioblastosis after gastric-bypass surgery [J]. New England Journal of Medicine, 2005(3):249.
计量
  • 文章访问数:  172
  • HTML全文浏览量:  36
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 发布日期:  2013-06-12

目录

    /

    返回文章
    返回
    x 关闭 永久关闭